SynthesisPharmacoEconomics2023

Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan.

Taku Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.